Squawk on the Street DOJ Powell Probe Backlash, JPMorgan Chase's Earnings Beat, Eli Lilly CEO Exclusive 1/13/26
10 snips
Jan 13, 2026 David Ricks, the CEO of Eli Lilly and Company, joins the conversation to share insights on revolutionizing obesity therapies. He emphasizes the significance of their groundbreaking oral GLP-1s, designed to make treatment more accessible. Ricks discusses the ambitious $50 billion investment in manufacturing to support their expansion and innovative collaborations with NVIDIA to enhance drug discovery. The discussion also touches on the broader therapeutic potential of incretins, showcasing their impact beyond weight loss.
AI Snips
Chapters
Transcript
Episode notes
CPI Was Softer Than Expected
- December CPI was softer than feared despite high shelter and grocery inflation.
- Jim Cramer called the print "very soft" and sees energy possibly easing further.
DOJ Appears Politicized Over Powell Probe
- Jim Cramer argued the Justice Department looks politicized and diminished by targeting Jerome Powell.
- He said the real attack is on DOJ's credibility rather than the Fed's independence.
Central Bankers Rally Behind Fed Independence
- Global central bankers publicly defended Powell and Fed independence.
- Jamie Dimon warned politicizing the Fed could raise inflation expectations and increase rates over time.